Debt-to-equity of Armata Pharmaceuticals, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Armata Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Armata Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -229%, a 30% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Armata Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -229% +100% +30% 30 Sep 2025
Q2 2025 -259% +140% +35% 30 Jun 2025
Q1 2025 -291% +338% +54% 31 Mar 2025
Q4 2024 -305% +14514% +98% 31 Dec 2024
Q3 2024 -329% -870% -161% 30 Sep 2024
Q2 2024 -399% -623% -279% 30 Jun 2024
Q1 2024 -629% -782% -511% 31 Mar 2024
Q4 2023 -14819% -14921% -14588% 31 Dec 2023
Q3 2023 541% +441% +442% 30 Sep 2023
Q2 2023 224% +128% +133% 30 Jun 2023
Q1 2023 153% +60% +65% 31 Mar 2023
Q4 2022 102% +11% +12% 31 Dec 2022
Q3 2022 100% +26% +35% 30 Sep 2022
Q2 2022 96% +20% +27% 30 Jun 2022
Q1 2022 93% +18% +24% 31 Mar 2022
Q4 2021 91% +23% +35% 31 Dec 2021
Q3 2021 74% +13% +22% 30 Sep 2021
Q2 2021 76% +21% +38% 30 Jun 2021
Q1 2021 75% +24% +48% 31 Mar 2021
Q4 2020 68% +2% +3% 31 Dec 2020
Q3 2020 61% -6% -8.7% 30 Sep 2020
Q2 2020 55% -9% -14% 30 Jun 2020
Q1 2020 51% -8% -13% 31 Mar 2020
Q4 2019 66% +26% +64% 31 Dec 2019
Q3 2019 67% +44% +190% 30 Sep 2019
Q2 2019 64% +41% +177% 30 Jun 2019
Q1 2019 58% +31% +117% 31 Mar 2019
Q4 2018 40% 0% -0.4% 31 Dec 2018
Q3 2018 23% -47% -67% 30 Sep 2018
Q2 2018 23% -42% -65% 30 Jun 2018
Q1 2018 27% -30% -52% 31 Mar 2018
Q4 2017 40% -11% -21% 31 Dec 2017
Q3 2017 70% +24% +53% 30 Sep 2017
Q2 2017 66% +18% +38% 30 Jun 2017
Q1 2017 57% -22% -28% 31 Mar 2017
Q4 2016 51% -139% -73% 31 Dec 2016
Q3 2016 46% -261% -85% 30 Sep 2016
Q2 2016 47% -557% -92% 30 Jun 2016
Q1 2016 78% +1137% 31 Mar 2016
Q4 2015 190% +577% 31 Dec 2015
Q3 2015 307% +607% 30 Sep 2015
Q2 2015 605% 30 Jun 2015
Q1 2015 -1059% 31 Mar 2015
Q4 2014 -387% 31 Dec 2014
Q3 2014 -300% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.